title: Overactive bladder, under scrutiny, gets a new treatment.
authors.forename: Alisa
authors.initials: A
authors.lastname: Opar
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use*; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D006801:Humans; D022702:Receptors, Adrenergic, beta-3 / Q000187:drug effects*; D013844:Thiazoles / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
chemical_list: D000083:Acetanilides; D000318:Adrenergic beta-Agonists; D022702:Receptors, Adrenergic, beta-3; D013844:Thiazoles; C520025:mirabegron